← All trials
NCT02214563
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2014
- Primary completion
- Mar 1, 2016
- Completion date
- Dec 1, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 90
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- Osaka UniversityLead sponsor
- The Japan Kidney FoundationCollaborator
- Molecular Physiological Chemistry Laboratory, Inc.Collaborator
- Higashikouri HospitalCollaborator
- Futaba clinicCollaborator
- Akebono clinicCollaborator
- Osaka UniversitySponsor investigator
- Osaka UniversityStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.